Found: 17
Select item for more details and to access through your institution.
Adjusting for time of infection or positive test when estimating the risk of a post-infection outcome in an epidemic.
- Published in:
- Statistical Methods in Medical Research, 2022, v. 31, n. 10, p. 1942, doi. 10.1177/09622802221107105
- By:
- Publication type:
- Article
Authors' reply to the discussion of 'Estimation of reproduction numbers in real time: conceptual and statistical challenges' by Pellis et al. in Session 3 of the Royal Statistical Society's Special Topic Meeting on COVID‐19 transmission: 11 June 2021
- Published in:
- Journal of the Royal Statistical Society: Series A (Statistics in Society), 2022, v. 185, n. 1, p. S153, doi. 10.1111/rssa.12984
- By:
- Publication type:
- Article
Estimation of reproduction numbers in real time: Conceptual and statistical challenges.
- Published in:
- Journal of the Royal Statistical Society: Series A (Statistics in Society), 2022, v. 185, n. 1, p. S112, doi. 10.1111/rssa.12955
- By:
- Publication type:
- Article
Understanding the infection severity and epidemiological characteristics of mpox in the UK.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45110-8
- By:
- Publication type:
- Article
Evolutionary bet-hedging in structured populations.
- Published in:
- Journal of Mathematical Biology, 2021, v. 82, n. 5, p. 1, doi. 10.1007/s00285-021-01597-z
- By:
- Publication type:
- Article
Approximating Quasi-Stationary Behaviour in Network-Based SIS Dynamics.
- Published in:
- Bulletin of Mathematical Biology, 2022, v. 84, n. 1, p. 1, doi. 10.1007/s11538-021-00964-7
- By:
- Publication type:
- Article
EpiBeds: Data informed modelling of the COVID-19 hospital burden in England.
- Published in:
- PLoS Computational Biology, 2022, v. 18, n. 9, p. 1, doi. 10.1371/journal.pcbi.1010406
- By:
- Publication type:
- Article
Deterministic epidemic models overestimate the basic reproduction number of observed outbreaks.
- Published in:
- Infectious Disease Modelling (2468-2152), 2024, v. 9, n. 3, p. 680, doi. 10.1016/j.idm.2024.02.007
- By:
- Publication type:
- Article
Nowcasting the 2022 mpox outbreak in England.
- Published in:
- PLoS Computational Biology, 2023, v. 19, n. 9, p. 1, doi. 10.1371/journal.pcbi.1011463
- By:
- Publication type:
- Article
Best practices for estimating and reporting epidemiological delay distributions of infectious diseases.
- Published in:
- PLoS Computational Biology, 2024, v. 20, n. 10, p. 1, doi. 10.1371/journal.pcbi.1012520
- By:
- Publication type:
- Article
The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47199-3
- By:
- Publication type:
- Article
The rapid replacement of the SARS-CoV-2 Delta variant by Omicron (B.1.1.529) in England.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 652, p. 1, doi. 10.1126/scitranslmed.abo5395
- By:
- Publication type:
- Article
Understanding the leading indicators of hospital admissions from COVID-19 across successive waves in the UK.
- Published in:
- Epidemiology & Infection, 2023, v. 151, p. 1, doi. 10.1017/S0950268823001449
- By:
- Publication type:
- Article
Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
- Published in:
- Epidemiology & Infection, 2023, v. 151, p. 1, doi. 10.1017/S0950268822001935
- By:
- Publication type:
- Article
Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
- Published in:
- Epidemiology & Infection, 2022, v. 151, p. 1, doi. 10.1017/S0950268822001935
- By:
- Publication type:
- Article
How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.
- Published in:
- BMC Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12916-024-03444-6
- By:
- Publication type:
- Article
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07239-z
- By:
- Publication type:
- Article